Trastuzumab Emtansine (T-DM1)-Induced Porto-Sinusoidal Vascular Disorder: A Case Report.
Аннотация
T-DM1 is used to treat early and advanced HER2-positive breast cancer and has a favorable toxicity profile. Porto-sinusoidal vascular disorder (PSVD) is a rare complication of this treatment, and its pathophysiology is not fully understood. A 43-year-old female patient was diagnosed with locally advanced HER2-overexpressing breast cancer, treated with primary chemotherapy, followed by surgery and adjuvant radiotherapy and trastuzumab. Distant relapse was identified four years later, and T-DM1 was started, leading to a complete response. Given the alterations in liver enzymes and signs of portal hypertension observed in a CT scan, a liver biopsy was performed, revealing lesions compatible with PSVD. PSVD related to T-DM1 was assumed, T-DM1 was suspended, and the patient remained under surveillance. She remained asymptomatic and with no evidence of disease for seven months. T-DM1-related PSVD is a rare complication of T-DM1 treatment that should not be overlooked. Clinical suspicion is essential for diagnosis, and T-DM1 suspension is the only known treatment.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.